Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST
   PubMed Web of Science ®Google Scholar
• Furlow B. Occupational exposures are important factors in COPD and other lung diseases. Lancet Respir Med. 2019;7(10):840. doi:10.1016/S2213-2600(19)30304-2
   PubMed Web of Science ®Google Scholar
• Peng Y, Li X, Cai S, et al. Prevalence and characteristics of COPD among pneumoconiosis patients at an occupational disease prevention institute: a cross-sectional study. BMC Pulm Med. 2018;18(1):22. doi:10.1186/s12890-018-0581-0
   PubMedGoogle Scholar
• Fan Y, Xu W, Wang Y, et al. Association of occupational dust exposure with combined chronic obstructive pulmonary disease and pneumoconiosis: a cross-sectional study in China. BMJ Open. 2020;10(9):e038874. doi:10.1136/bmjopen-2020-038874
   PubMed Web of Science ®Google Scholar
• Duan JX, Cheng W, Zeng YQ, et al. Characteristics of patients with chronic obstructive pulmonary disease exposed to different environmental risk factors: a large cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2020;15:2857–2867. doi:10.2147/COPD.S267114
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Sluis-Cremer GK, Abramowitz JA. Emphysema type in relation to silica dust exposure in South African gold miners[J]. Am Rev Respir Dis. 1991;143(6):1241–1247. doi:10.1164/ajrccm/143.6.1241
   PubMedGoogle Scholar
• Ruckley VA, Fernie JM, Chapman JS, et al. Comparison of radiographic appearances with associated pathology and lung dust content in a group of coalworkers[J]. Occup Environ Med. 1984;41(4):459–467. doi:10.1136/oem.41.4.459
   Google Scholar
• Tse LA, Yu IT, Leung CC, et al. Mortality from non-malignant respiratory diseases among people with silicosis in Hong Kong: exposure-response analyses for exposure to silica dust. Occup Environ Med. 2007;64(2):87–92. doi:10.1136/oem.2006.028506
   PubMed Web of Science ®Google Scholar
• Worlds Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003.
   Google Scholar
• López-Campos JL, Quintana Gallego E, Carrasco Hernández L. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503–1515. doi:10.2147/COPD.S170848
   PubMed Web of Science ®Google Scholar
• Unni EJ, Gupta S, Sternbach N. Using the medication adherence reasons scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence. Respir Med. 2021;179:106337. doi:10.1016/j.rmed.2021.106337
   PubMed Web of Science ®Google Scholar
• Nishi SPE, Maslonka M, Zhang W, et al. Pattern and adherence to maintenance medication use in medicare beneficiaries with chronic obstructive pulmonary disease: 2008–2013. Chronic Obstr Pulm Dis. 2018;5(1):16–26.
   PubMed Web of Science ®Google Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-3
   PubMed Web of Science ®Google Scholar
• López-Pintor E, Grau J, González I, et al. Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: study in 53 community pharmacies. Respir Med. 2021;176:106280. doi:10.1016/j.rmed.2020.106280
   PubMed Web of Science ®Google Scholar
• Duarte-de-araújo A, Teixeira P, Hespanhol V, et al. COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–2773. doi:10.2147/COPD.S160982
   PubMed Web of Science ®Google Scholar
• Ierodiakonou D, Sifaki-Pistolla D, Kampouraki M, et al.; Greek UNLOCK group. Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece. BMC Pulm Med. 2020;20(1):253. doi:10.1186/s12890-020-01296-3
   PubMed Web of Science ®Google Scholar
• Yu AP, Guerin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486–496. doi:10.3111/13696998.2011.594123
   PubMedGoogle Scholar
• Wisniewski D, Porzezinska M, Gruchala-Niedoszytko M, et al. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104. doi:10.5603/PiAP.2014.0015
   PubMedGoogle Scholar
• Koehorst-Ter Huurne K, Groothuis-Oudshoorn CG, vanderValk PD, et al. Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1683–1690. doi:10.2147/COPD.S161374
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Świątoniowska N, Chabowski M, Polański J, Mazur G, Jankowska-Polańska B. Adherence to therapy in chronic obstructive pulmonary disease: a systematic review. Adv Exp Med Biol. 2020;1271:37–47.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 2006;61(9):744–746. doi:10.1136/thx.2006.061648
   PubMed Web of Science ®Google Scholar
• Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray M. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413–422. doi:10.1345/aph.1L496
   PubMed Web of Science ®Google Scholar
• George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325–1334. doi:10.2147/PPA.S209532
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PM, Celli B, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi:10.1186/1465-9921-11-122
   PubMed Web of Science ®Google Scholar
• Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9(1):60. doi:10.1186/2049-6958-9-60
   PubMedGoogle Scholar
• Dhamane AD, Schwab P, Hopson S, et al. Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:115–122. doi:10.2147/COPD.S114802
   PubMed Web of Science ®Google Scholar
• Zhang M, Tang T, Wan M, et al. Self-reported reasons for treatment nonadherence in chronic obstructive pulmonary disease (COPD) patients: a 24-week prospective cohort study in China. Ann Palliat Med. 2020;9(5):3495–3505. doi:10.21037/apm-20-1741
   PubMed Web of Science ®Google Scholar
• Mueller S, Wilke T, Bechtel B, et al. Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1–11. doi:10.1016/j.rmed.2016.11.008
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Riario-Sforza GG. Effect of patient education on adherence to drug treatment for chronic obstructive pulmonary disease. Ann Thorac Med. 2011;6(4):242–243. doi:10.4103/1817-1737.84783
   PubMed Web of Science ®Google Scholar
• Wang HQ, Jia JL, Jiang ZQ, et al. Analysis of health service utilization and its influencing factors among patients with pneumoconiosis in china. Biomed Environ Sci. 2021;34(1):83–88.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Thomashow B, Sapir T, et al. Does Evaluation and management of COPD Follow therapeutic strategy recommendations? Chronic Obstr Pulm Dis. 2021;8(2):230–242.
   PubMed Web of Science ®Google Scholar
• Basu S, Garg S, Sharma N, et al. Enhancing Medication adherence through improved patient-provider communication: the 6A’s of intervention. J Assoc Physicians India. 2019;67(7):69–71.
   PubMedGoogle Scholar
• Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J. 2007;14(1):25–29. doi:10.1155/2007/161652
   PubMed Web of Science ®Google Scholar
• Huetsch JC, Uman JE, Udris EM, et al. Predictors of adherence to inhaled medications among veterans with COPD. J Gen Intern Med. 2012;27(11):1506–1512. doi:10.1007/s11606-012-2130-5
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63(9):831–838. doi:10.1136/thx.2007.086041
   PubMed Web of Science ®Google Scholar
• Price D, Keininger DL, Viswanad B, et al. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Int J Chron Obstruct Pulmon Dis. 2018;13:695–702. doi:10.2147/COPD.S149404
   PubMed Web of Science ®Google Scholar
• Gruenberger JB, Vietri J, Keininger DL, et al. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:937–944. doi:10.2147/COPD.S123744
   PubMed Web of Science ®Google Scholar
• Zeng Y, Cai S, Chen Y, et al. Current Status of the Treatment of COPD in China: a Multicenter Prospective Observational Study. Int J Chron Obstruct Pulmon Dis. 2020;15:3227–3237. doi:10.2147/COPD.S274024
   PubMed Web of Science ®Google Scholar